Literature DB >> 12507903

Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation.

Daniela Bruch-Gerharz1, Oliver Schnorr, Christoph Suschek, Karl-Friedrich Beck, Josef Pfeilschifter, Thomas Ruzicka, Victoria Kolb-Bachofen.   

Abstract

Abnormal proliferation of keratinocytes in the skin appears crucial to the pathogenesis of psoriasis, but the underlying mechanisms remain unknown. Nitric oxide (NO), released from keratinocytes at high concentrations, is considered a key inhibitor of cellular proliferation and inducer of differentiation in vitro. Although high-output NO synthesis is suggested by the expression of inducible NO synthase (iNOS) mRNA and protein in psoriasis lesions, the pronounced hyperproliferation of psoriatic keratinocytes may indicate that iNOS activity is too low to effectively deliver anti-proliferative NO concentrations. Here we show that arginase 1 (ARG1), which substantially participates in the regulation of iNOS activity by competing for the common substrate L-arginine, is highly overexpressed in the hyperproliferative psoriatic epidermis and is co-expressed with iNOS. Expression of L-arginine transporter molecules is found to be normal. Treatment of primary cultured keratinocytes with Th1-cytokines, as present in a psoriatic environment, leads to de novo expression of iNOS but concomitantly a significant down-regulation of ARG1. Persistent ARG1 overexpression in psoriasis lesions, therefore, may represent a disease-associated deviation from normal expression patterns. Furthermore, the culturing of activated keratinocytes in the presence of an ARG inhibitor results in a twofold increase in nitrite accumulation providing evidence for an L-arginine substrate competition in human keratinocytes. High-output NO synthesis is indeed associated with a significant decrease in cellular proliferation as shown by down-regulation of Ki67 expression in cultured keratinocytes but also in short-term organ cultures of normal human skin. In summary, our data demonstrate for the first time a link between a human inflammatory skin disease, limited iNOS activity, and ARG1 overexpression. This link may have substantial implications for the pathophysiology of psoriasis and the development of new treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507903      PMCID: PMC1851107          DOI: 10.1016/S0002-9440(10)63811-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  Psoriasis: the plot thickens....

Authors:  M P Schön; T Ruzicka
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

2.  Regulation of apoptosis by p53 in UV-irradiated human epidermis, psoriatic plaques and senescent keratinocytes.

Authors:  Jian-Zhong Qin; Vijaya Chaturvedi; Mitchell F Denning; Patricia Bacon; Jeffry Panella; Divaker Choubey; Brian J Nickoloff
Journal:  Oncogene       Date:  2002-05-02       Impact factor: 9.867

3.  Letter: Role of arginase in the epidermis.

Authors:  D W Cotton; P D Mier
Journal:  Nature       Date:  1974-12-13       Impact factor: 49.962

4.  Kinetics of inhibition of rat liver and kidney arginases by proline and branched-chain amino acids.

Authors:  N Carvajal; S D Cederbaum
Journal:  Biochim Biophys Acta       Date:  1986-03-28

Review 5.  Nitric oxide and the immune response.

Authors:  C Bogdan
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

Review 6.  Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis.

Authors:  J G Krueger; J F Krane; D M Carter; A B Gottlieb
Journal:  J Invest Dermatol       Date:  1990-06       Impact factor: 8.551

7.  Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis.

Authors:  B J Nickoloff; G D Karabin; J N Barker; C E Griffiths; V Sarma; R S Mitra; J T Elder; S L Kunkel; V M Dixit
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

8.  T cells involved in psoriasis vulgaris belong to the Th1 subset.

Authors:  J F Schlaak; M Buslau; W Jochum; E Hermann; M Girndt; H Gallati; K H Meyer zum Büschenfelde; B Fleischer
Journal:  J Invest Dermatol       Date:  1994-02       Impact factor: 8.551

9.  Interleukin 1 alpha, tumor necrosis factor alpha, and interferon gamma in psoriasis.

Authors:  T Gomi; T Shiohara; T Munakata; K Imanishi; M Nagashima
Journal:  Arch Dermatol       Date:  1991-06

10.  Temporal expression of different pathways of 1-arginine metabolism in healing wounds.

Authors:  J E Albina; C D Mills; W L Henry; M D Caldwell
Journal:  J Immunol       Date:  1990-05-15       Impact factor: 5.422

View more
  41 in total

1.  Explaining decreased nitric oxide production in psoriatic lesions: arginase 1 overexpression versus calcitonin gene-related peptide.

Authors:  Mohammad Reza Namazi
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 2.  Arginase: a critical regulator of nitric oxide synthesis and vascular function.

Authors:  William Durante; Fruzsina K Johnson; Robert A Johnson
Journal:  Clin Exp Pharmacol Physiol       Date:  2007-09       Impact factor: 2.557

3.  Characterization of cationic amino acid transporters (hCATs) 1 and 2 in human skin.

Authors:  Kristin Jaeger; Friedrich Paulsen; Johannes Wohlrab
Journal:  Histochem Cell Biol       Date:  2008-01-03       Impact factor: 4.304

4.  Serum vascular endothelial growth factor, transforming growth factor β1, and nitric oxide levels in patients with psoriasis vulgaris: their correlation to disease severity.

Authors:  Abdel-Raheim M A Meki; Hani Al-Shobaili
Journal:  J Clin Lab Anal       Date:  2014-03-22       Impact factor: 2.352

5.  Arginase I levels are decreased in the plasma of pediatric patients with atopic dermatitis.

Authors:  Victoria Dimitriades; Paulo C Rodriguez; Jovanny Zabaleta; Augusto C Ochoa
Journal:  Ann Allergy Asthma Immunol       Date:  2014-07-11       Impact factor: 6.347

6.  Parasite-derived arginase influences secondary anti-Leishmania immunity by regulating programmed cell death-1-mediated CD4+ T cell exhaustion.

Authors:  Zhirong Mou; Helen M Muleme; Dong Liu; Ping Jia; Ifeoma B Okwor; Shiby M Kuriakose; Stephen M Beverley; Jude E Uzonna
Journal:  J Immunol       Date:  2013-03-04       Impact factor: 5.422

7.  Hyperpolarized [6-13C,15N3]-Arginine as a Probe for in Vivo Arginase Activity.

Authors:  Andrew Cho; Roozbeh Eskandari; Kristin L Granlund; Kayvan R Keshari
Journal:  ACS Chem Biol       Date:  2019-03-27       Impact factor: 5.100

8.  Oxidative-nitrosative stress and post-translational protein modifications: implications to lung structure-function relations. Arginase modulates NF-kappaB activity via a nitric oxide-dependent mechanism.

Authors:  Karina Ckless; Albert van der Vliet; Yvonne Janssen-Heininger
Journal:  Am J Respir Cell Mol Biol       Date:  2007-01-11       Impact factor: 6.914

9.  Local suppression of T cell responses by arginase-induced L-arginine depletion in nonhealing leishmaniasis.

Authors:  Manuel Modolell; Beak-San Choi; Robert O Ryan; Maggie Hancock; Richard G Titus; Tamrat Abebe; Asrat Hailu; Ingrid Müller; Matthew E Rogers; Charles R M Bangham; Markus Munder; Pascale Kropf
Journal:  PLoS Negl Trop Dis       Date:  2009-07-14

Review 10.  Arginase: an emerging key player in the mammalian immune system.

Authors:  Markus Munder
Journal:  Br J Pharmacol       Date:  2009-09-17       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.